Man Group PLC Apellis Pharmaceuticals, Inc. Transaction History

Man Group PLC

$35.6 Billion
Q4 2024

A detailed history of Man Group PLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Man Group PLC holds 49,292 shares of APLS stock, worth $1.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

49,292

Previous 16,742 194.42%

Holding current value

$1.36 Million

Previous $482,000 226.14%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$26.18 - $35.42 $852,159 - $1.15 Million	32,550 Added 194.42%	49,292 $1.57 Million
Q3 2024 Nov 14, 2024	SELL	$28.84 - $41.15 $1.74 Million - $2.49 Million	-60,487 Reduced 78.32%	16,742 $482,000
Q2 2024 Aug 14, 2024	BUY	$38.07 - $59.71 $2.94 Million - $4.61 Million	77,229 New	77,229 $2.96 Million
Q1 2023 May 15, 2023	SELL	$46.59 - $66.96 $4.73 Million - $6.81 Million	-101,628 Reduced 96.07%	4,156 $274,000
Q4 2022 Feb 14, 2023	SELL	$43.24 - $61.04 $1.63 Million - $2.3 Million	-37,601 Reduced 26.22%	105,784 $5.47 Million
Q3 2022 Nov 14, 2022	BUY	$44.76 - $69.66 $5.36 Million - $8.35 Million	119,860 Added 509.5%	143,385 $9.79 Million
Q2 2022 Aug 15, 2022	SELL	$35.07 - $59.21 $1.41 Million - $2.39 Million	-40,327 Reduced 63.16%	23,525 $1.06 Million
Q1 2022 May 16, 2022	BUY	$35.46 - $54.12 $2.26 Million - $3.46 Million	63,852 New	63,852 $3.24 Million
Q4 2021 Feb 14, 2022	SELL	$30.74 - $49.16 $716,242 - $1.15 Million	-23,300 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$31.4 - $69.84 $2.08 Million - $4.62 Million	-66,125 Reduced 73.94%	23,300 $768,000
Q2 2021 Aug 16, 2021	SELL	$40.9 - $64.9 $3.91 Million - $6.21 Million	-95,649 Reduced 51.68%	89,425 $5.65 Million
Q1 2021 May 17, 2021	SELL	$40.8 - $57.39 $1.47 Million - $2.07 Million	-36,126 Reduced 16.33%	185,074 $7.94 Million
Q4 2020 Feb 16, 2021	SELL	$30.79 - $57.2 $821,661 - $1.53 Million	-26,686 Reduced 10.77%	221,200 $12.7 Million
Q3 2020 Nov 16, 2020	SELL	$25.89 - $33.65 $244,919 - $318,329	-9,460 Reduced 3.68%	247,886 $7.48 Million
Q2 2020 Aug 14, 2020	BUY	$24.8 - $38.49 $6.06 Million - $9.41 Million	244,384 Added 1885.39%	257,346 $8.41 Million
Q1 2020 May 15, 2020	BUY	$17.91 - $44.33 $232,149 - $574,605	12,962 New	12,962 $347,000

Others Institutions Holding APLS

# of Institutions

302

Shares Held

123M

Call Options Held

2.63M

Put Options Held

845K

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.02B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account